| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Center for Advanced Biotechnology and Medicine [M. J. K., R. B-G., W. A. B-P., N. D., M. M. S., C. A-S.], Departments of Neuroscience [M. J. K., R. B-G., W. A. B-P., C. A-S.], Medicine [C. A-S.], and Pediatrics [N. D., M. M. S.], The Cancer Institute of New Jersey [M. M. S., C. A-S.], University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854; Department of Anatomy, University of California, San Francisco, California 94143 [Y. W., S. W. H., G. R. C.]; and Center for Comparative Medicine, University of California, Davis, California 95616 [R. D. C.]
Recent studies of human cancers and mutant mouse models have implicated the Nkx3.1 homeobox gene as having a key role in prostate carcinogenesis. Consistent with such a role, here we show that Nkx3.1 displays growth-suppressing activities in cell culture, and that aged Nkx3.1 mutant mice display histopathological defects resembling prostatic intraepithelial neoplasia (PIN), the presumed precursor of human prostate cancer. Using a tissue recombination approach, we found that PIN-like lesions from Nkx3.1 mutants can undergo progressively severe histopathological alterations after serial transplantation in nude mice. Our findings indicate that Nkx3.1 loss-of-function is a critical event in prostate cancer initiation, and that Nkx3.1 mutant mice accurately model early stages of prostate carcinogenesis. More generally, our tissue recombination assay provides an empirical test to examine the relationship of PIN to prostate carcinoma.
This article has been cited by other articles:
![]() |
C.-W. Chua, Y.-T. Chiu, H.-F. Yuen, K.-W. Chan, K. Man, X. Wang, M.-T. Ling, and Y.-C. Wong Suppression of Androgen-Independent Prostate Cancer Cell Aggressiveness by FTY720: Validating Runx2 as a Potential Antimetastatic Drug Screening Platform Clin. Cancer Res., July 1, 2009; 15(13): 4322 - 4335. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Blando, M. Portis, F. Benavides, A. Alexander, G. Mills, B. Dave, C. J. Conti, J. Kim, and C. L. Walker PTEN Deficiency Is Fully Penetrant for Prostate Adenocarcinoma in C57BL/6 Mice via mTOR-Dependent Growth Am. J. Pathol., May 1, 2009; 174(5): 1869 - 1879. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Kessler, H. Hasegawa, S. N. Brun, B. A. Emmenegger, Z.-J. Yang, J. W. Dutton, F. Wang, and R. J. Wechsler-Reya N-myc alters the fate of preneoplastic cells in a mouse model of medulloblastoma Genes & Dev., January 15, 2009; 23(2): 157 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.M. Shen, X. Wang, K.D. Economides, D. Walker, and C. Abate-Shen Progenitor Cells for the Prostate Epithelium: Roles in Development, Regeneration, and Cancer Cold Spring Harb Symp Quant Biol, January 15, 2009; (2009) sqb.2008.73.050v1. [Abstract] [PDF] |
||||
![]() |
H. Zhang, M. H. Muders, J. Li, F. Rinaldo, D. J. Tindall, and K. Datta Loss of NKX3.1 Favors Vascular Endothelial Growth Factor-C Expression in Prostate Cancer Cancer Res., November 1, 2008; 68(21): 8770 - 8778. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Yao, A. Parwani, C. Maier, W. D. Heston, and D. J. Bacich Moderate Expression of Prostate-Specific Membrane Antigen, a Tissue Differentiation Antigen and Folate Hydrolase, Facilitates Prostate Carcinogenesis Cancer Res., November 1, 2008; 68(21): 9070 - 9077. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Holmes, J. S. Song, X. S. Liu, M. Brown, and J. S. Carroll Nkx3-1 and LEF-1 Function as Transcriptional Inhibitors of Estrogen Receptor Activity Cancer Res., September 15, 2008; 68(18): 7380 - 7385. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ouyang, W. J. Jessen, H. Al-Ahmadie, A. M. Serio, Y. Lin, W.-J. Shih, V. E. Reuter, P. T. Scardino, M. M. Shen, B. J. Aronow, et al. Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer Cancer Res., April 1, 2008; 68(7): 2132 - 2144. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, R. A. Fillmore, and W. E. Zimmer Structural and Functional Analysis of Domains Mediating Interaction Between the Bagpipe Homologue, Nkx3.1 and Serum Response Factor Experimental Biology and Medicine, March 1, 2008; 233(3): 297 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Guan, P. Pungaliya, X. Li, C. Uquillas, L. N. Mutton, E. H. Rubin, and C. J. Bieberich Ubiquitination by TOPORS Regulates the Prostate Tumor Suppressor NKX3.1 J. Biol. Chem., February 22, 2008; 283(8): 4834 - 4840. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-T. Wu, S. Altuwaijri, W. A. Ricke, S.-P. Huang, S. Yeh, C. Zhang, Y. Niu, M.-Y. Tsai, and C. Chang Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor PNAS, July 31, 2007; 104(31): 12679 - 12684. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bowen, A. Stuart, J.-H. Ju, J. Tuan, J. Blonder, T. P. Conrads, T. D. Veenstra, and E. P. Gelmann NKX3.1 Homeodomain Protein Binds to Topoisomerase I and Enhances Its Activity Cancer Res., January 15, 2007; 67(2): 455 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Bethel, D. Faith, X. Li, B. Guan, J. L. Hicks, F. Lan, R. B. Jenkins, C. J. Bieberich, and A. M. De Marzo Decreased NKX3.1 Protein Expression in Focal Prostatic Atrophy, Prostatic Intraepithelial Neoplasia, and Adenocarcinoma: Association with Gleason Score and Chromosome 8p Deletion. Cancer Res., November 15, 2006; 66(22): 10683 - 10690. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Banach-Petrosky, X. Ouyang, H. Gao, K. Nader, Y. Ji, N. Suh, R. S. DiPaola, and C. Abate-Shen Vitamin d inhibits the formation of prostatic intraepithelial neoplasia in nkx3.1; pten mutant mice. Clin. Cancer Res., October 1, 2006; 12(19): 5895 - 5901. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Gao, X. Ouyang, W. A. Banach-Petrosky, W. L. Gerald, M. M. Shen, and C. Abate-Shen Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer PNAS, September 26, 2006; 103(39): 14477 - 14482. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Singh and L. Johnson Using genetically engineered mouse models of cancer to aid drug development: an industry perspective. Clin. Cancer Res., September 15, 2006; 12(18): 5312 - 5328. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhou, A. Flesken-Nikitin, D. C. Corney, W. Wang, D. W. Goodrich, P. Roy-Burman, and A. Yu. Nikitin Synergy of p53 and Rb Deficiency in a Conditional Mouse Model for Metastatic Prostate Cancer Cancer Res., August 15, 2006; 66(16): 7889 - 7898. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Gao, X. Ouyang, W. A. Banach-Petrosky, M. M. Shen, and C. Abate-Shen Emergence of Androgen Independence at Early Stages of Prostate Cancer Progression in Nkx3.1; Pten Mice Cancer Res., August 15, 2006; 66(16): 7929 - 7933. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Dai, O. Kim, Y. Xie, Z. Guo, K. Xu, B. Wang, X. Kong, J. Melamed, H. Chen, C. J. Bieberich, et al. Tyrosine Kinase Etk/BMX Is Up-regulated in Human Prostate Cancer and Its Overexpression Induces Prostate Intraepithelial Neoplasia in Mouse Cancer Res., August 15, 2006; 66(16): 8058 - 8064. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Lyons, E. Lim, A. O. Clermont, J. Dusich, L. Zhu, K. D. Campbell, R. J. Coffee, D. S. Grass, J. Hunter, T. Purchio, et al. Noninvasive Bioluminescence Imaging of Normal and Spontaneously Transformed Prostate Tissue in Mice. Cancer Res., May 1, 2006; 66(9): 4701 - 4707. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, B. Guan, S. Maghami, and C. J. Bieberich NKX3.1 Is Regulated by Protein Kinase CK2 in Prostate Tumor Cells Mol. Cell. Biol., April 15, 2006; 26(8): 3008 - 3017. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zhong, G. Saribekyan, C.-P. Liao, M. B. Cohen, and P. Roy-Burman Cooperation between FGF8b Overexpression and PTEN Deficiency in Prostate Tumorigenesis Cancer Res., February 15, 2006; 66(4): 2188 - 2194. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yoshida, R. Broaddus, W. Cheng, S. Xie, and H. Naora Deregulation of the HOXA10 Homeobox Gene in Endometrial Carcinoma: Role in Epithelial-Mesenchymal Transition Cancer Res., January 15, 2006; 66(2): 889 - 897. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ouyang, T. L. DeWeese, W. G. Nelson, and C. Abate-Shen Loss-of-Function of Nkx3.1 Promotes Increased Oxidative Damage in Prostate Carcinogenesis Cancer Res., August 1, 2005; 65(15): 6773 - 6779. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Asatiani, W.-X. Huang, A. Wang, E. Rodriguez Ortner, L. R. Cavalli, B. R. Haddad, and E. P. Gelmann Deletion, Methylation, and Expression of the NKX3.1 Suppressor Gene in Primary Human Prostate Cancer Cancer Res., February 15, 2005; 65(4): 1164 - 1173. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kuzmichev, R. Margueron, A. Vaquero, T. S. Preissner, M. Scher, A. Kirmizis, X. Ouyang, N. Brockdorff, C. Abate-Shen, P. Farnham, et al. Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation PNAS, February 8, 2005; 102(6): 1859 - 1864. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Gao, X. Ouyang, W. Banach-Petrosky, A. D. Borowsky, Y. Lin, M. Kim, H. Lee, W.-J. Shih, R. D. Cardiff, M. M. Shen, et al. A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis PNAS, December 7, 2004; 101(49): 17204 - 17209. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gary, R. Azuero, G. S. Mohanty, W. C. Bell, I.-E. A. Eltoum, and S. A. Abdulkadir Interaction of Nkx3.1 and p27kip1 in Prostate Tumor Initiation Am. J. Pathol., May 1, 2004; 164(5): 1607 - 1614. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Mo, S. Li, X. Yang, and M. Xiang Role of the Barhl2 homeobox gene in the specification of glycinergic amacrine cells Development, April 1, 2004; 131(7): 1607 - 1618. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Shappell, G. V. Thomas, R. L. Roberts, R. Herbert, M. M. Ittmann, M. A. Rubin, P. A. Humphrey, J. P. Sundberg, N. Rozengurt, R. Barrios, et al. Prostate Pathology of Genetically Engineered Mice: Definitions and Classification. The Consensus Report from the Bar Harbor Meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee Cancer Res., March 15, 2004; 64(6): 2270 - 2305. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. I. Skotheim, K. S. Korkmaz, T. I. Klokk, V. M. Abeler, C. G. Korkmaz, J. M. Nesland, S. D. Fossa, R. A. Lothe, and F. Saatcioglu NKX3.1 Expression Is Lost in Testicular Germ Cell Tumors Am. J. Pathol., December 1, 2003; 163(6): 2149 - 2154. [Abstract] [Full Text] |
||||
![]() |
G. J. Miller, H. L. Miller, A. van Bokhoven, J. R. Lambert, P. N. Werahera, O. Schirripa, M. S. Lucia, and S. K. Nordeen Aberrant HOXC Expression Accompanies the Malignant Phenotype in Human Prostate Cancer Res., September 15, 2003; 63(18): 5879 - 5888. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Abate-Shen, W. A. Banach-Petrosky, X. Sun, K. D. Economides, N. Desai, J. P. Gregg, A. D. Borowsky, R. D. Cardiff, and M. M. Shen Nkx3.1; Pten Mutant Mice Develop Invasive Prostate Adenocarcinoma and Lymph Node Metastases Cancer Res., July 15, 2003; 63(14): 3886 - 3890. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Park, J. E. Walls, J. J. Galvez, M. Kim, C. Abate-Shen, M. M. Shen, and R. D. Cardiff Prostatic Intraepithelial Neoplasia in Genetically Engineered Mice Am. J. Pathol., August 1, 2002; 161(2): 727 - 735. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |